access to medicines advocacy africa aids arthritis asia asthma bill and melinda gates foundation burden of illness canada canadian agency for drugs and technologies in health cancer cardiovascular disease china chiropractic services chronic disease civil society common drug review comparative effectiveness compulsory licensing cost containment counterfeit medicines dengue fever developing countries diabetes disease management drug approval emerging markets europe fda formularies france generic medicines global health health insurance health outcomes health policy health promotion health service utilization health spending health systems health technology assessment igwg impact importation incontinence incremental innovation india information to patients innovation intellectual property internet pharmacies japan liability malaria medicaid medical liability medicare ministry of health minnesota mood disorders neglected tropical diseases obesity ontario patents patient advocacy patient safety patient-centered care patients pharmaceutical industry pharmacists prescription drugs prescription medicines price controls pricing of medicines public health public-private partnerships rare diseases reimbursement republic of korea seniors substandard medicines supply chain thailand trips tuberculosis unaids unicef united nations usa vaccines venezuela world bank world health assembly world health organization world intellectual property office world trade organization